CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 181 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2024. The put-call ratio across all filers is 2.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $28,045,105 | -11.0% | 757,771 | +0.9% | 0.27% | -7.6% |
| Q1 2024 | $31,521,988 | +105.0% | 751,060 | +93.7% | 0.29% | +73.7% |
| Q4 2023 | $15,374,278 | +419.7% | 387,652 | +260.6% | 0.17% | +377.1% |
| Q3 2023 | $2,958,290 | +60.0% | 107,496 | +97.2% | 0.04% | +59.1% |
| Q2 2023 | $1,849,151 | -7.4% | 54,499 | -1.8% | 0.02% | -18.5% |
| Q1 2023 | $1,995,847 | +14.8% | 55,471 | -13.9% | 0.03% | 0.0% |
| Q2 2022 | $1,738,000 | -91.2% | 64,454 | -88.9% | 0.03% | -91.6% |
| Q1 2022 | $19,727,000 | +96.4% | 579,192 | +122.9% | 0.32% | +122.2% |
| Q4 2021 | $10,042,000 | – | 259,895 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 844,000 | $32,612,000 | 6.92% |
| Octagon Capital Advisors LP | 761,398 | $29,420,000 | 5.72% |
| ACUTA CAPITAL PARTNERS, LLC | 340,098 | $13,141,000 | 5.52% |
| Ghost Tree Capital, LLC | 350,000 | $13,524,000 | 4.85% |
| Kynam Capital Management, LP | 226,726 | $8,761,000 | 4.68% |
| VR Adviser, LLC | 865,116 | $33,428,000 | 4.57% |
| Ikarian Capital, LLC | 593,800 | $22,946,000 | 3.42% |
| TSP Capital Management Group, LLC | 253,696 | $9,803,000 | 3.27% |
| Ikarian Capital, LLC | 451,200 | $17,433,000 | 2.60% |
| Ikarian Capital, LLC | 419,216 | $16,198,000 | 2.41% |